Stay updated on First-Line Tarlatamab Combo in ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for first-line tarlatamab combination therapy in extensive-stage small cell lung cancer is available, with details on study design, participation criteria, outcomes, and sites. It also includes the sponsor’s data-sharing plan and related study information.
    Difference
    100%
    Check dated 2026-11-09T12:29:20.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains an error page rather than showing the study record. Its footer now identifies the site revision as v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T11:36:54.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T11:00:47.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T11:51:45.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site revision shown in the footer changed from v3.7.0 to v3.7.1, while the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T13:56:00.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, making the study record inaccessible. The content that previously displayed the study details and locations appears to be replaced by the error notice.
    Difference
    21%
    Check dated 2026-09-21T22:08:32.000Z thumbnail image

Stay in the know with updates to First-Line Tarlatamab Combo in ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.